Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Arcadia Biosciences Q2 Sales $3.86M Beat $2.29M Estimate

Arcadia Biosciences (NASDAQ:RKDA) reported quarterly sales of $3.86 million which beat the analyst consensus estimate of $2.29 million by 68.47 percent. This is a 174.59 percent increase over sales of $1.41 million the
byBenzinga Newsdesk
August 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Arcadia Biosciences (NASDAQ:RKDA) reported quarterly sales of $3.86 million which beat the analyst consensus estimate of $2.29 million by 68.47 percent. This is a 174.59 percent increase over sales of $1.41 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts